Transplantation Proceedings
Volume 34, Issue 7 , Pages 2520-2522 , November 2002

Sirolimus and FTY720: new approaches to transplant immunosuppression

  • B.D Kahan

      Affiliations

    • Division of Immunology and Organ Transplantation, University of Texas–Houston, Houston, Texas, USA
    • Corresponding Author InformationAddress reprint requests to Barry D. Kahan, PhD, MD, Division of Immunology and Organ Transplantation, University of Texas–Houston, 6431 Fannin, Suite 60240, Houston TX, USA.

References 

  1. Kahan BD, Camardo JS. Transplantation. 2001;72:1181
  2. Kahan BD, Kramer WG. Clin Pharmacol Ther. 2001;70:74
  3. Hong JC, Kahan BD. Transplantation. 2001;71:1320
  4. Wang ME, Tejpal N, Qu X, et al.  Transplantation. 1998;65:899
  5. Troncoso P, Stepkowski SM, Wang ME, et al.  Transplantation. 1999;67:145
  6. Kahan BD, Chodoff L, Leichtman J, et al.  Transplantation. 2000;69(Suppl 1):S132
  7. Tedesco H, Kahan BD, Mouad G, et al.  Am J Transplantation. 2001;1(Suppl 1):243

☆ This work was supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK 38016-14).

PII: S0041-1345(02)03472-3

Transplantation Proceedings
Volume 34, Issue 7 , Pages 2520-2522 , November 2002

Article Tools

* Image Usage & Resolution